Jiang Rensheng & family (#830)
- $ 5 B
- Vaccines
- China
- M
- 72 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Jiang Rensheng is the chairman of Shenzhen-listed vaccine firm Chongqing Zhifei Biological Products. A longtime distribution partner of Merck, Zhifei won the Chinese sales rights to the U.S. pharma's HPV drug in 2018. In 2023, Jiang took his antibody drug maker Chongqing Genrix Biopharmaceutical public on the Shanghai Stock Exchange. Prior to striking out on his own, he worked as a primary school teacher and a government health official.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Jiang Rensheng & family’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Jiang Rensheng & family’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $5.1B
(May 4, 2026)
© Iconic Billionaires